Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial

Journal of the American College of Cardiology

Volumn 31, Issue 1, 1998, Pages 31-36

  Khan, M Musa ^a   Ellis, Stephen G ^b   Aguirre, Frank V ^c   Weisman, Harlan F ^d   Wildermann, Nancy M ^e   Califf, Robert M ^e   Topol, Eric J ^b   Kleiman, Neal S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; HEPARIN; PLACEBO;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; EMERGENCY SURGERY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0031932050     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00423-3     Document Type: Article

References (36)

1. Cowley MJ, DiSciascio G, Rehr RB, Vetrovec GW. Angiographic observations and clinical relevance of coronary thrombus in unstable angina pectoris. Am J Cardiol. 63:1989;108E-113E.
2. Roberts WC, Kragel AH, Gertz SD, Roberts CS. Coronary arteries in unstable angina pectoris, acute myocardial infarction, and sudden coronary death. Am Heart J. 127:1994;1588-1593.
3. Kragel AH, Gertz SD, Roberts WC. Morphologic comparison of frequency and types of acute lesions in the major epicardial coronary arteries in unstable angina pectoris, sudden coronary death and acute myocardial infarction. J Am Coll Cardiol. 18:1991;801-808.
4. Mizuno K, Arakawa K, Isojima K, et al. Angioscopy, coronary thrombi and acute coronary syndromes. Biomed Pharmacother. 47:1993;187-191.
5. Taeymans Y, Theroux P, Lesperance J, Waters D. Quantitative angiographic morphology of the coronary artery lesions at risk of thrombotic occlusion. Circulation. 85:1992;78-85.
6. Ip JH, Fuster V, Israel D, Badimon L, Badimon J, Chesebro JH. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol. 17:(6 Suppl B):1991;77B-88B.
7. Liu MW, Roubin GS, King SB 3d. Restenosis after coronary angioplasty potential biologic determinants and role of intimal hyperplasia . Circulation. 79:1989;1374-1387.
8. McBride W, Lange RA, Hillis LD. Restenosis after successful coronary angioplasty pathophysiology and prevention . N Engl J Med. 318:1988;1734-1737.
9. White CJ, Ramee SR, Collins TJ, Jain SP, Escobar A. Coronary angioscopy of abrupt occlusion after angioplasty. J Am Coll Cardiol. 25:1995;1681-1684.
10. Arora RR, Platko WP, Bhadwar K, Simpfendorfer C. Role of intracoronary thrombus in acute complications during percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diagn. 16:1989;226-229.
11. Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ. Abrupt vessel closure complicating coronary angioplasty clinical, angiographic and therapeutic profile . J Am Coll Cardiol. 19:1992;926-935.
12. Verns E, Repetto S, Boscarini M, Onofri M, Qing LG, Binaghi G. Management of complicated coronary angioplasty by intracoronary urokinase and immediate re-angioplasty. Cathet Cardiovasc Diagn. 19:1990;116-122.
13. Mooney MR, Mooney JF, Goldenberg IF, Almquist AK, Van Tassel RA. Percutaneous transluminal coronary angioplasty in the setting of large intracoronary thrombi. Am J Cardiol. 65:1990;427-431.
14. Laskey MA, Deutsch E, Hirshfield JW Jr, Kussmaul WG, Bettesbarn E, Laskey WK. Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in patients with coronary arterial thrombus. Am J Cardiol. 65:1990;179-182.
15. Vaitkus PT, Herrman HC, Laskey WK. Management and immediate outcome of patients with intracoronary thrombus during percutaneous transluminal coronary angioplasty. Am Heart J. 124:1992;1-8.
16. Ellis SG, Roubin GS, King SB III, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation. 77:1988;372-379.
17. Sugrue DD, Holmes DR Jr, Smith HC, et al. Coronary artery thrombus as a risk factor for acute vessel occlusion during percutaneous transluminal coronary angioplasty improving results . Br Heart J. 56:1986;62-66.
18. Detre KM, Holmes DR Jr, Hohnbkoy R, et al. Incidence and consequences of periprocedural occlusion the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry . Circulation. 82:1990;739-750.
19. Mabin TA, Holmes DR Jr, Smith HC, et al. Intracoronary thrombus role in coronary occlusion complicating percutaneous transluminal coronary angioplasty . J Am Coll Cardiol. 5:(2 Pt 1):1985;198-202.
20. Deligonul U, Gabliani GI, Caralis DG, Kern MJ, Vandormael MG. Percutaneous transluminal coronary angioplasty in patients with intracoronary thrombus. Am J Cardiol. 62:1988;474-476.
21. Coller BS, Peenchke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombosthinic-like state in normal platelets and binds to glycoprotein IIb/IIIa. J Clin Invest. 72:1997;325-338.
22. Bates ER, McGillam MJ, Mickelson JK, Pitt B, Mancini GB. A monoclonal antibody against the platelet glycoprotein IIb/IIIa receptor complex prevents platelet aggregation and thrombosis in a canine model of coronary angioplasty. Circulation. 84:1991;2463-2469.
23. Ellis SG, Bates ER, Schaible T, Weisman HF, Pitt B, Topol EJ. Prospects for the use of antagonists to the platelet glycoprotein IIb/IIIa receptor to prevent post-angioplasty restenosis and thrombosis [review]. J Am Coll Cardiol. 17:(6 Suppl B):1991;89B-95B.
24. Yasuda T, Gold HK, Fallon JT, et al. Monoclonal antibody against the platelet glycoprotein IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs. J Clin Invest. 81:1988;1284-1291.
25. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty the EPIC Investigation . N Engl J Med. 330:1994;956-961.
26. Topol EJ. Prevention of cardiovascular ischemic complications with new platelet glycoprotein IIb/IIIa inhibitors [review]. Am Heart J. 130:(3 Pt 2):1995;666-672.
27. Topol EJ, Califf RM, Weisman HF, et al., for the EPIC Investigators. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 1994;343:881-6.
28. de Feyter PJ, Brand M, Jasman G, Domburg D, Serruys P, Suryspranata H. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty frequency, prediction, management, and follow-up . Circulation. 83:1991;927-936.
29. Violaris AG, Melkert R, Herman JR, Serruys PW. Role of angiographically identifiable thrombus on long-term luminal renarrowing after coronary angioplasty a quantitative angiographic analysis . Circulation. 93:1996;889-897.
30. White CJ, Ramee SR, Collins TJ, et al. Coronary thrombi increase PTCA risk angioscopy as a clinical tool . Circulation. 93:1996;253-258.
31. Ip JH, Fuster V, Chesebro JH. Syndromes of accelerated atherosclerosis role of vascular injury and SMC proliferation . Am J Cardiol. 60:(Suppl B):1987;10B-16B.
32. Califf RM, Fortin DF, Frid DJ, et al. Restenosis after coronary angioplasty an overview . J Am Coll Cardiol. 17:(6 Suppl B):1991;2B-13B.
33. den Heijer P, van Dijk RB, Hillege HL, Pentinga ML, Serruys PW, Lie KI. Serial angioscopic and angiographic observations during the first hour after successful coronary angioplasty a preamble to a multicenter trial addressing angioscopic markers for restenosis . Am Heart J. 128:1994;656-663.
34. Teirstein PS, Schatz RA, DeNardo SJ, Jensen EE, Johnson AD. Angioscopic versus angiographic detection of thrombus during coronary interventional procedures. Am J Cardiol. 75:1995;1083-1087.
35. den Heijer P, Foley DP, Escamed J, et al. Angioscopic versus angiographic detection of intimal dissection and intracoronary thrombus [see comments]. J Am Coll Cardiol. 24:1994;649-654.
36. Uretsky BF, Deays BG, Courrihan PC, Ragosta M. Angioscopic evaluation of incompletely obstructing coronary intraluminal filling defects comparison to angiography . Cathet Cardiovasc Diagn. 33:1994;323-329.